MedTrace Logo

Efficacy and Safety of Aripiprazole in First Episode Psychosis

NCT01026584 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2012-02-13

No results posted yet for this study

Summary

The aim of the study is to investigate the efficacy and safety of aripiprazole in patients with first episode psychosis.

Conditions

  • First Episode Psychosis

Interventions

DRUG

Aripiprazole

6 week prospective study

Sponsors & Collaborators

  • Korea Otsuka Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Chonbuk National University Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026584 on ClinicalTrials.gov